8-K ·Filed Apr 21, 2026

MMM

3M CO
BULLISH
Impact 7/10
Horizonweeks Processed5mo ago SEC0000066740-26-000171
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The strong adjusted EPS beat and reaffirmed guidance suggest 3M's transformation is gaining traction; monitor upcoming quarters for sustained margin improvement and organic sales recovery.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
MMM ▲ +9.01% at T+60d
LONG call ✓ call won +9.01% · α vs SPY +2.39% · entry $148.40 → $161.77
Entry anchored
Apr 20, 03:59 PM ET
via exchange tick
T+1d
-1.86%
call -1.86% · α -2.88%
$145.64
settled 5mo ago
T+5d
-1.71%
call -1.71% · α -2.80%
$145.86
settled 5mo ago
T+20d
+2.79%
call +2.79% · α -2.13%
$152.53
settled 5mo ago
T+60d
+9.01%
call +9.01% · α +2.39%
$161.77
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

3M reported Q1 2026 adjusted EPS of $2.14, up 14% YoY and beating consensus by 6.1%, on strong margin expansion and stable sales. The company reiterated full-year 2026 guidance, signaling confidence in its transformation strategy despite a volatile environment.

Key Financial Metrics

EPS
$2.14
est $2.02 · +6.1%
Revenue
$6.0B
est $6.0B · +0.5% · +1.3% YoY
Rating
beat
Free Cash Flow
$541.0M

Key Facts

  • Adjusted EPS of $2.14, up 14% YoY and beat consensus of $2.02 by 6.1%
  • GAAP EPS of $1.23, down 40% YoY due to special items including a $0.67 gain on Solventum ownership
  • Sales of $6.0B, up 1.3% YoY with organic sales down 1.4%; adjusted sales up 3.9% YoY
  • Adjusted operating margin of 23.8%, up 30 bps YoY
  • Reiterated full-year 2026 guidance: adjusted EPS $8.50-$8.70, sales growth of 4%, margin expansion of 70-80 bps

Financial Impact

Adjusted EPS beat consensus by $0.12, driven by margin expansion and lower litigation costs

epsrevenueoperating_marginfree_cash_flow

Risk Factors

  • GAAP EPS decline due to special items could pressure sentiment
  • Organic sales declined 1.4% YoY, indicating underlying demand weakness

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000066740-26-000171
Document: mmm-20260421.htm0000066740-26-000171
Document: 0000066740-26-000171-index-headers.html0000066740-26-000171
Document: 0000066740-26-000171-index.html0000066740-26-000171
Document: 0000066740-26-000171.txt0000066740-26-000171
8-K Data (Synthetic)0000066740-26-000171
14 reports for MMM
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MMM — sortable, filterable
TypeNow
Sep 3, 2026
29d ago
424B5
NEUTRAL ★ 4/10
$168.31 $164.97▼ −1.98%▼ −0.84%$162.14 (−3.67%)
Aug 22, 2026
5w ago
Institutional Cluster
MIXED ★ 5/10
$179.01 $171.83▼ −4.01%▼ −4.48%$162.14 (−9.43%)
Aug 19, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$180.66 $180.00▼ −0.37%▲ +0.02%$162.14 (−10.25%)
Aug 14, 2026
6w ago
Press Release
NEUTRAL ★ 4/10
$182.65 $178.96▼ −2.02%▼ −0.65%$162.14 (−11.23%)
Jul 24, 2026
10w ago
Insider Cluster
NEUTRAL ★ 4/10
$172.62 $176.07▲ +2.00%▲ +1.63%$162.14 (−6.07%)
Jul 23, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$169.59 $176.07▲ +3.82%▲ +3.35%$162.14 (−4.40%)
Jul 21, 2026
10w ago
8-K
BULLISH ★ 7/10
$170.76 $178.23▲ +4.37%▲ +5.60%$162.14 (−5.05%)
Jul 7, 2026
12w ago
Press Release
BEARISH ★ 5/10
$158.01 $156.58▲ +0.91%▲ +1.46%$162.14 (−2.61%)
Jul 5, 2026
12w ago
Institutional Cluster
MIXED ★ 6/10
$159.15 $157.52▼ −1.02%▼ −1.51%$162.14 (+1.88%)
Jun 8, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$153.85 $158.23▲ +2.85%▲ +0.74%$162.14 (+5.39%)
Showing 10 of 14

US Market Status

Market Open — Closes in 3h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access